Finanza

Notizie Discussioni Tecnici Previsione Stagionalità Opzioni

Margine EBITDA % su Candel Therapeutics, Inc..

Dati annuali

2020

2021

2022

2023

‪‪−28,00 K‬‬

‪‪−21,00 K‬‬

‪‪−14,00 K‬‬

‪‪−7,00 K‬‬

‪0,00‬

Periodo

Valore

Variazione

Variazione %

2023

—

—

—

2022

‪‪−26,99 K‬‬

‪‪−6,59 K‬‬

‪−32,33‬%

2021

‪‪−20,40 K‬‬

‪‪−9,42 K‬‬

‪−85,83‬%

2020

‪‪−10,98 K‬‬

‪‪−3,78 K‬‬

‪−52,54‬%

Dati trimestrali

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−28,00 K‬‬

‪‪−21,00 K‬‬

‪‪−14,00 K‬‬

‪‪−7,00 K‬‬

‪0,00‬

Periodo

Valore

Variazione

Variazione %

Q3 '24

—

—

—

Q2 '24

—

—

—

Q1 '24

—

—

—

Q4 '23

—

—

—

Q3 '23

—

—

—

Q2 '23

—

—

—

Q1 '23

—

—

—

Q4 '22

‪‪−25,24 K‬‬

+‪‪2,57 K‬‬

+‪9,25‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q3 '20